Since the late 1960s, continuous epidural blockade has radically altered the practice of modem obstetrics. In Australia, epidurals are almost always administered by anaesthetists. Despite the great efficacy of the technique, the risks to both mother and fetus, although low, are very significant. I • 3 Maternal deaths from high spinal block or local anaesthetic toxicity and fetal morbidity and mortality from decreased placental blood flow do occur.
To detect and avoid these potential disasters the most important factors are a safe epidural technique, sound nursing practices, appropriate clinical monitoring, and availability of skilled clinicians. [4] [5] [6] This paper deals with monitoring the parturient receiving epidural analgesia with local anaesthestic drugs only. Although epidural opioids in labour are being investigated widely at present, their possible advantages have not been proved nor their use widely accepted. A discussion of this use of opioids or other drugs then, is beyond the scope of this paper.
Likewise, specific monitoring requirements of parturients with severe hypertensive or other specific disease states are not discussed.
Analgesia in labour may alter the physiology of the mother, her fetus, and the function of the uteroplacental unit. Oxygen delivery to maternal vital organs and the fetus should not be compromised. Before any analgesia is administered in labour, the anaesthetist must be aware of the condition of the mother, her fetus, the stage and progress of the labour, and the intended mode of delivery. After administration, monitoring should continue to focus on the mother, the fetus and utero-placental function.
MATERNAL MONITORING

General
The mother's conscious and emotional state, respiration, pulse rate and rhythm, central and peripheral perfusion and level of pain should be monitored frequently. Pregnant patients receiving epidural analgesia should not be permitted to lie in the supine position without some form of uterine displacement. Aorto-caval compression is a significant hazard beyond twenty weeks' gestation, especially if there is any degree of sympathetic blockade.? No parturient who has received an epidural should ever be left unattended. 8 
Pulse and Blood Pressure
These parameters are measured because it is easy to do so and because changes in their values are usually reasonable indicators of cardiac output. Many studies have demonstrated that hypotension is the most common complication of epidural blockade ( Table 1) . The incidence will not be high if adequate assessment of the patient has been carried out, appropriate intravenous volume expansion is undertaken prior to administering the block, aortocaval compression is avoided and the epidural block performed carefully and extended slowly with small intermittent doses of local anaesthetic while monitoring the parturient appropriately.
Monitoring for early hypotension is necessary not only to detect an extended epidural block, but also to identify an inadvertent subdural (SD) or subarachnoid (SA) block, early signs of which are changes in pulse rate and blood pressure (BP).
There are few data available at present on the use of automated oscillometric sphygmomanometers in pregnancy in general, or in labour in particular, but they are used widely. It is known however, that these monitors may be inaccurate when BP is low or high.9 Diastolic BP assessment in obstetrics is common, and these monitors have some limitations with respect to diastolic BP measurement. Incorrect cuff size too is an important source of error in BP measurement. 9 Monitoring BP and pulse rate should be done between uterine contractions. During strong contractions systolic BP may increase by up to 25 mmHg and diastolic BP by up to 15 mmHg. to 'Significant hypotension' is an empirical term with no absolute numerical value, particularly as far as the fetus is concerned. 11 Hypotension must be regarded as 'significant' whenever signs of decreased perfusion of the placenta or maternal organs are seen.
Such signs can be detected only by careful observation of the mother and her fetus.
Intravascular injection
Methods which may be used to detect impending local anaesthetic toxicity, due to intravascular injection of local anaesthetics are: 1. The aspiration test.
Injection of a test dose of local anaesthetic and
monitoring for changes in conscious state, dysphasia, circumoral numbness or tingling, tinnitus, apprehension, drowsiness, increased uterine contraction pain and twitching. 3. Injection of a test dose of a 'marker', such as adrenaline (up to 15 micrograms), and then monitoring the mother for palpitations, anxiety, visual disturbances, increased pulse rate and/or BP or ECG changes. However, there are shortcomings with each of these tests, and the whole issue of monitoring for intravascular injection is highly controversial. 12 • 1 ?
The use of adrenaline has been shown to be a good marker of intravascular placement in premedicated surgical patients when monitored with an ECG,18 and in the non beta-blocked patient, 15 micrograms (3 ml of 1 in 200,000 solution), will increase the heart rate by 30 bpm in about 30 seconds and will last for about one minute. In labour, however, a mother in pain, already with increased circulating catecholamines and a tachycardia, is unlikely to exhibit such a predictable response. 12 The response to intravenous adrenaline may be so transient that it requires a continuous monitor to detect it, and even then, the many false positives make interpretation difficult.
The safety of adrenaline use must also be examined, even though it has been reported that epidural adrenaline maintains intervillous blood flow. 17 If injected intravenously, intervillous blood flow will decrease. 19 In sheep, this reduction in flow has been equated to that seen during strong uterine contractions. 20 Adrenaline also affects uterine contractility21 especially in large doses 22 ; this is considered significant in some circumstances. 13 It is not our practice to use adrenaline test doses routinely in labour. They are used however for anaesthesia blocks with maternal ECG, pulse and BP monitoring. Lignocaine 2% with adrenaline (1 in 200,000) is used in more than 95% epidural blocks for caesarean section in our unit, where such anaesthesia is always administered incrementally in the theatre with full maternal and frequent fetal heart monitoring.
We believe that acute local anaesthetic toxicity reactions can be avoided by the fractional or incremental injection technique which was advocated by Covino and others long before the Albright report was published. 24 Each small dose should be regarded as a 'test' dose and clinically monitored accordingly. Aspiration should be performed. The use of up to 5 ml increments ofless concentrated solutions, e.g. bupivacaine 0.25%, may virtually eliminate acute toxic reactions. 12 . 14
Subarachnoid (or Subdural) Injection
Monitoring for inadvertent SA or SD block may be achieved by: 1. The aspiration test, whereby aspiration of the catheter or needle is performed looking for the presence of CSF, which is confirmed by glucose oxidase stick ('Dextrostix'@ or other) testing; 2. Injection of a test dose while monitoring for rapid sympathetic, sensory or motor block. The test dose technique has similar shortcomings to its use as a test for intravascular placement. Interpretation of the aspiration test may be difficult if liquid (saline or local anaesthetic solution) has been injected down the needle prior to catheter placement. To the experienced operator this is not a problem, but if doubt exists about the composition of the fluid returning, it should be tested for glucose, even though false positives and negatives may occur. Failure to detect subarachnoid placement also occurs. 1, 25, 26 The main limitation of the test dose is the variation in spread and onset time of some local anaesthetics, particularly isobaric bupivacaine. [27] [28] [29] [30] [31] For the initial test dose, 2-chloroprocaine (not available in Australia) is favoured by some American anaesthesiologists, while lignocaine 1.5%-2.0% with adrenaline is recommended by others. 28 Hyperbaric solutions of lignocaine probably have a more rapid onset of action than bupivacaine and more predictable spread, and have thus been recommended for test dosing in this contextp-31 Weak solutions, if used for the initial or test dose, are less likely to reliably detect SA or SD placement. This is most important when a subsequent larger dose is administered (e.g. for anaesthesia for operative delivery), which may result in the rapid onset of a high spinal block. 25 It has been argued however, that weak solutions are suitable as 'test' doses. 32 The test is positive for misplacement (e.g. intravascular, extravertebral) when analgesia does not develop, or develops weakly in only one or two segments. SD placement of needle or catheter is not detected by aspiration,24 nor by a lignocaine test dose. 33 The clinical signs of SD block -extensive sensory block, 'moderate' hypotension (SBP down to about 80 mmHg) and frequent Homer's syndrome -are gradual in onset and relatively rapid in recovery. Only ongoing vigilant clinical assessment and monitoring will detect SD placement.
It should be remembered that the 'test dose controversy' is just that -a controversy. EVERY dose should be regarded as a test dose.",32,
As top-up doses are sometimes given by midwives, proper training of staff and availability of resuscitation equipment and skilled personnel are of paramount importance.4-6 After some tragic deaths, the lack of ready availability of these resources has lead to the withdrawal of epidural services from some small British hospitals. 4 (A comprehensive discussion of this controversy by Chestnut 32 was published last year and is strongly recommended.)
Pulse oximetry
There are insufficient data on the use of maternal pulse oximetry to recommend its general use in labour, whether or not an epidural is in use, but it is useful in specific cases and when systemic opioidl nitrous oxide analgesia is used. 34
FETAL MONITORING
The subject of fetal monitoring is well reported in recent obstetric anaesthesia texts l7 ,21 and in specific review papers. 35 ,36 The purpose of such monitoring is to detect fetal compromise at an early stage so as to allow corrective action to be taken so preventing death and morbidity.
The most common types of monitoring in clinical use include:-1. Recording of the fetal heart rate (FHR) by scalp clip ECG, external Doppler ultrasonography, or direct auscultation. ) . The anaesthetist administering and supervising epidurals needs to be aware of the benefits and pitfalls of FHR monitoring. The role of continuous electronic FHR monitoring in the low-risk obstetric population is controversiaP6,37 and its exact place in monitoring parturients receiving epidurals has not been evaluated fully.
Traditional interpretation of the FHR tracing has been based largely on specific patterns of bradycardia and tachycardia.
Currently, increasingly greater emphasis is being placed on the presence or absence of FHR variability (FHR V) as a marker of fetal well-being. Scalp electrocardiography reflects FHRV best, as it measures the R-R interval between successive ECG complexes. Doppler ultrasound on the other hand measures cardiac pulse wave intervals and so is oversensitive to interference, especially where atrial and ventricular contraction is asynchronous. Modern monitors use auto-correlation to average out this asynchronism, but in doing so lose sensitivity in determining true FHRV. 38 FHRY can also be influenced by a number of factors, including drugs ( Table 2) . Even uncomplicated epidural analgesics will alter FHRY. Lignocaine can decrease FHRy39 whereas 2-chloroprocaine does not. 40 The effects of bupivacaine are variable. 40 It remains to be proved whether FHR changes are more sensitive end-points for epidural monitoring than the maternal monitoring methods discussed in this paper. However, hypoxic (and other) FHR changes observed in humans have been recreated in sheep by reducing uteroplacental blood flow -the most important factor in fetal oxygen delivery. 41 Despite some doubts about the limitations of sensitivity and specificity of current FHR monitoring technology, many Level III obstetric units (including our own unit) use cardiotocographic (CTG) monitoring for all epidural patients. Most perinatologists, obstetricians and obstetric anaesthetists, at least in the U .S.A., use CTG monitoring when known risk factors are present. 32 In at-risk cases it is preferable for the status of the fetus to be determined before an epidural is commenced. Continuous CTG monitoring will frequently provide this information, supplemented where necessary, by a fetal scalp pH and/or P0 2 measurement.
Ideally then, in at-risk cases, and perhaps in all cases, the CTG should be reviewed before the epidural is administered, and any doubts discussed with the obstetrician. 42
If CTG facilities are unavailable, the fetal heart rate should be checked by other means. Auscultation every five minutes, either with a Pinard or Doppler stethoscope, for twenty minutes after each dose of local anaesthetic, and thereafter every fifteen minutes during labour is a reasonable routine. 42 On a more positive note, placental blood flow may improve after an epidural. This may be seen on the CTG and confirmed by Doppler ultrasonography. 43, 44 UTERINE MONITORING (ToeOGRAPHY) As the fetal heart and nervous system are usually more sensitive to the effects of drugs or to subtle changes in maternal cardiorespiratory physiology, the uterine monitor is of less value to the anaesthetist than the FHR record, but in some instances it may detect unwanted drug or other effects. Changes in tone after intravenous local anaesthetic, adrenaline or other drug administration can be detected. 2 1,22 Alterations in uteroplacental blood flow secondary to aorto-caval compression or sympathetic blockade may alter uterine activity.
Tocographic monitoring is most commonly performed by the use of an external pressure transducer.
This of course gives no information about the intrauterine pressure, but provides comparative quantitative information about the frequency, amplitude and duration of contractions. As the tocogram is recorded continuously with the FHR (the CTG), the two recordings are considered together, so increasing the usefulness of the FHR tracing.
Some units use intrauterine catheters (connected to a pressure transducer) to measure intrauterine pressure directly. Pressures > 2500 kilopascals/15 minutes can be tolerated by an uncompromised term fetus. 45 
